UTHR earnings call for the period ending June 30, 2019.
News & Analysis: United Therapeutics
The stock has now fallen nearly 30% since the end of March.
UTHR earnings call for the period ending March 31, 2019.
UTHR earnings call for the period ending December 31, 2018.
The company moved to immediately monetize a promising drug candidate. For a cool $800 million up-front payment, investors can't complain.
UTHR earnings call for the period ending September 30, 2018.
A new collaboration is funneling tens of millions of dollars onto the diabetes company’s balance sheet.
Shares soar for the second day in a row. What can explain the bullish move?
Shares are soaring following the company's announcement of a new partnership agreement. Here's what investors need to know.
These stocks are definitely inexpensive. But are they buys?